Kyverna Therapeutics, Inc. - 8-K Filing
Kyverna Therapeutics reports positive one-year data for miv-cel in stiff person syndrome and generalized myasthenia gravis trials (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $KYTX